TickerFactsScreenerDevelopers

Immunocore Holdings plc (IMCR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$143.11M2022: -$49.21M2023: $2.94M2024: $26.06M2025: -$10.71M-$10.71M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.71M-141.1%
2024$26.06M+786.4%
2023$2.94M+106.0%
2022-$49.21M+65.6%
2021-$143.11M—